South and Central America Breast Reconstruction Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Technology, Type; Placement, Procedure

Inframammary Segment has the Largest Share of Technology in the South and Central America Breast Reconstruction Market during 2021-2028

According to a new market research study on “South and Central America Breast Reconstruction Market to 2028 - COVID-19 Impact and Regional Analysis and Forecast by Technology, Type, Placement and Procedure,” is expected to reach US$ 46.3 million by 2028 from US$ 31.2 million in 2021. The market is estimated to grow at a CAGR of 5.8% from 2021 to 2028. The report provides trends prevailing in the South and Central America breast reconstruction market along with the drivers and restraints pertaining to the market growth. The growth of this market is estimated to grow owing to key driving factors such as the high prevalence of breast cancer and new product launches and FDA approvals are the key factors driving the market growth. However, the market is expected experiencing slow growth during the forecast period owing to the low awareness regarding reimbursement policies.

Countries in Brazil and Argentina are among the top destinations in the world for aesthetic procedures. However, the outbreak of COVID-19 has severely impacted the flow of medical services in the region. In addition, the countries are famous for medical tourism, which is also affected by the pandemic. Brazil, Argentina, Peru, Chile, Uruguay, Colombia are affected by the second wave of corona infection. Among which Brazil has registered the majority of the deaths. As of May 2021, around 411,854 lives have already been lost in Brazil, which is a sign of the second wave of COVID19 infection. The regular practice is more complex where rates of immediate breast reconstruction (IBR) pre-COVID-19 were high; Brazil's overall breast reconstruction rates were 29% before the pandemic, higher than recorded in the UK National Mastectomy and Breast Reconstruction Audit (21%). However, the COVID-19 specific guidelines issued by the Association of Breast Surgery in the UK in 2020 dramatically changed IBR. Approximately 30% reported a continuation of the practice during the pandemic. Even with these difficulties resulting from the pandemic, options were acknowledged to maintain institutional features. Nevertheless, it is expected that the region is likely to impose a second lockdown, which will eventually hamper the healthcare industry in the area. Moreover, countries are significantly dependent on the US and European countries for their medical resources. Thus, the market in the region has experienced a significant slowdown and is expected to face the same in the following two to three years.

The market for breast reconstruction market is segmented into technology, type, placement, and procedure. Based on technology, the breast reconstruction market is segmented into inframammary, peri-areolar, trans-axillary, and transumbilical. In 2020, the inframammary by technology segment accounted for the largest share of the market. Growth of this segment is attributed to rising emphasis on aesthetic appearance and rising number of product launches. However, peri-areolar technology segment is estimated to register the highest CAGR during the forecast period.

Allergan Plc, Mentor Worldwide LLC (Subsidiary of Johnson & Johnson), GC Aesthetics PLC, POLYTECH Health & Aesthetics GmbH, Establishment Labs S.A. HANSBIOMED CO. LTD, and Groupe Sebbin SAS are among the leading companies in the South and Central America breast reconstruction market. The companies are focused on adopting organic growth strategies such as product launches and expansions to sustain their position in the dynamic market. For instance, in May 2020, AbbVie announced that it has completed its acquisition of Allergan plc following receipt of regulatory approval from all government authorities required by the transaction agreement and approval by the Irish High Court.

The report segments the South and Central America Breast Reconstruction market as follows:

By Technology

• Inframammary
• Peri-Areolar
• Trans-Axillary
• Transumbilical

By Type

• Breast Implants
• Implant’s accessories

By Placement

• Dual Plane Insertion
• Subglandular Insertion
• Submuscular Insertion

By Procedure

• Immediate Procedures
• Delayed Procedures
• Revision Procedures

By Country

• South and Central America
• Brazil
• Argentina
• Rest of South and Central America

Reasons to buy:

• Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the South and Central America breast reconstruction market
• Highlights key business priorities in order to assist companies to realign their business strategies
• The key findings and recommendations highlight crucial progressive industry trends in the South and Central America breast reconstruction market, thereby allowing players across the value chain to develop effective long-term strategies
• Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
• Scrutinize in-depth South and Central America market trends and outlook coupled with the factors driving the breast reconstruction market, as well as those hindering it
• Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing and distribution